Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1975 1
1976 3
1977 5
1978 2
1979 4
1980 7
1981 7
1982 5
1983 4
1984 3
1985 4
1986 3
1987 11
1988 10
1989 12
1990 11
1991 15
1992 19
1993 19
1994 19
1995 13
1996 17
1997 13
1998 11
1999 15
2000 15
2001 21
2002 27
2003 20
2004 24
2005 33
2006 51
2007 53
2008 53
2009 45
2010 41
2011 40
2012 53
2013 64
2014 63
2015 73
2016 70
2017 97
2018 82
2019 95
2020 105
2021 54
Text availability
Article attribute
Article type
Publication date

Search Results

1,305 results
Results by year
Filters applied: . Clear all
Page 1
Pertuzumab, trastuzumab, and docetaxel in HER2-positive metastatic breast cancer.
Swain SM, Baselga J, Kim SB, Ro J, Semiglazov V, Campone M, Ciruelos E, Ferrero JM, Schneeweiss A, Heeson S, Clark E, Ross G, Benyunes MC, Cortés J; CLEOPATRA Study Group. Swain SM, et al. N Engl J Med. 2015 Feb 19;372(8):724-34. doi: 10.1056/NEJMoa1413513. N Engl J Med. 2015. PMID: 25693012 Free PMC article. Clinical Trial.
Luminal A Breast Cancer and Molecular Assays: A Review.
Gao JJ, Swain SM. Gao JJ, et al. Among authors: swain sm. Oncologist. 2018 May;23(5):556-565. doi: 10.1634/theoncologist.2017-0535. Epub 2018 Feb 22. Oncologist. 2018. PMID: 29472313 Free PMC article. Review.
Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA): end-of-study results from a double-blind, randomised, placebo-controlled, phase 3 study.
Swain SM, Miles D, Kim SB, Im YH, Im SA, Semiglazov V, Ciruelos E, Schneeweiss A, Loi S, Monturus E, Clark E, Knott A, Restuccia E, Benyunes MC, Cortés J; CLEOPATRA study group. Swain SM, et al. Lancet Oncol. 2020 Apr;21(4):519-530. doi: 10.1016/S1470-2045(19)30863-0. Epub 2020 Mar 12. Lancet Oncol. 2020. PMID: 32171426 Clinical Trial.
The clinical implications of selective IgA deficiency.
Swain S, Selmi C, Gershwin ME, Teuber SS. Swain S, et al. J Transl Autoimmun. 2019 Nov 23;2:100025. doi: 10.1016/j.jtauto.2019.100025. eCollection 2019 Dec. J Transl Autoimmun. 2019. PMID: 32743511 Free PMC article. Review.
Pertuzumab, trastuzumab, and standard anthracycline- and taxane-based chemotherapy for the neoadjuvant treatment of patients with HER2-positive localized breast cancer (BERENICE): a phase II, open-label, multicenter, multinational cardiac safety study.
Swain SM, Ewer MS, Viale G, Delaloge S, Ferrero JM, Verrill M, Colomer R, Vieira C, Werner TL, Douthwaite H, Bradley D, Waldron-Lynch M, Kiermaier A, Eng-Wong J, Dang C; BERENICE Study Group. Swain SM, et al. Ann Oncol. 2018 Mar 1;29(3):646-653. doi: 10.1093/annonc/mdx773. Ann Oncol. 2018. PMID: 29253081 Free PMC article. Clinical Trial.
Anthracyclines in Early Breast Cancer: The ABC Trials-USOR 06-090, NSABP B-46-I/USOR 07132, and NSABP B-49 (NRG Oncology).
Blum JL, Flynn PJ, Yothers G, Asmar L, Geyer CE Jr, Jacobs SA, Robert NJ, Hopkins JO, O'Shaughnessy JA, Dang CT, Gómez HL, Fehrenbacher L, Vukelja SJ, Lyss AP, Paul D, Brufsky AM, Jeong JH, Colangelo LH, Swain SM, Mamounas EP, Jones SE, Wolmark N. Blum JL, et al. Among authors: swain sm. J Clin Oncol. 2017 Aug 10;35(23):2647-2655. doi: 10.1200/JCO.2016.71.4147. Epub 2017 Apr 11. J Clin Oncol. 2017. PMID: 28398846 Free PMC article. Clinical Trial.
1,305 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page